BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 32453919)

  • 1. Structure-Activity Relationships of Butyrophilin 3 Ligands.
    Wiemer AJ
    ChemMedChem; 2020 Jun; 15(12):1030-1039. PubMed ID: 32453919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on Vγ9Vδ2 T cell activation.
    Gu S; Sachleben JR; Boughter CT; Nawrocka WI; Borowska MT; Tarrasch JT; Skiniotis G; Roux B; Adams EJ
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7311-E7320. PubMed ID: 28807997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation.
    Yang Y; Li L; Yuan L; Zhou X; Duan J; Xiao H; Cai N; Han S; Ma X; Liu W; Chen CC; Wang L; Li X; Chen J; Kang N; Chen J; Shen Z; Malwal SR; Liu W; Shi Y; Oldfield E; Guo RT; Zhang Y
    Immunity; 2019 Apr; 50(4):1043-1053.e5. PubMed ID: 30902636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The butyrophilin 3A1 intracellular domain undergoes a conformational change involving the juxtamembrane region.
    Nguyen K; Li J; Puthenveetil R; Lin X; Poe MM; Hsiao CC; Vinogradova O; Wiemer AJ
    FASEB J; 2017 Nov; 31(11):4697-4706. PubMed ID: 28705810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
    Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
    J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Photo-Crosslinkable Biotin Derivative of the Phosphoantigen (E)-4-Hydroxy-3-Methylbut-2-Enyl Diphosphate (HMBPP) Activates Vγ9Vδ2 T Cells and Binds to the HMBPP Site of BTN3A1.
    Mattarei A; Enzinger M; Gu S; Karunakaran MM; Kimmel B; Berner N; Adams EJ; Herrmann T; Amslinger S
    Chemistry; 2017 Sep; 23(49):11945-11954. PubMed ID: 28631855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the Ligand-Binding Pocket of BTN3A1.
    Poe MM; Agabiti SS; Liu C; Li V; Teske KA; Hsiao CC; Wiemer AJ
    J Med Chem; 2019 Jul; 62(14):6814-6823. PubMed ID: 31268699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrophilin-2A1 Directly Binds Germline-Encoded Regions of the Vγ9Vδ2 TCR and Is Essential for Phosphoantigen Sensing.
    Karunakaran MM; Willcox CR; Salim M; Paletta D; Fichtner AS; Noll A; Starick L; Nöhren A; Begley CR; Berwick KA; Chaleil RAG; Pitard V; Déchanet-Merville J; Bates PA; Kimmel B; Knowles TJ; Kunzmann V; Walter L; Jeeves M; Mohammed F; Willcox BE; Herrmann T
    Immunity; 2020 Mar; 52(3):487-498.e6. PubMed ID: 32155411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
    Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
    Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
    Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
    Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human Vγ9Vδ2 T cells.
    Sandstrom A; Peigné CM; Léger A; Crooks JE; Konczak F; Gesnel MC; Breathnach R; Bonneville M; Scotet E; Adams EJ
    Immunity; 2014 Apr; 40(4):490-500. PubMed ID: 24703779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
    Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP
    Science; 2020 Feb; 367(6478):. PubMed ID: 31919129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.
    Salim M; Knowles TJ; Baker AT; Davey MS; Jeeves M; Sridhar P; Wilkie J; Willcox CR; Kadri H; Taher TE; Vantourout P; Hayday A; Mehellou Y; Mohammed F; Willcox BE
    ACS Chem Biol; 2017 Oct; 12(10):2631-2643. PubMed ID: 28862425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.
    Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M
    Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More.
    Herrmann T; Karunakaran MM
    Front Immunol; 2022; 13():876493. PubMed ID: 35371078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of a phosphoantigen prodrug that potently activates Vγ9Vδ2 T-lymphocytes.
    Hsiao CH; Lin X; Barney RJ; Shippy RR; Li J; Vinogradova O; Wiemer DF; Wiemer AJ
    Chem Biol; 2014 Aug; 21(8):945-54. PubMed ID: 25065532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
    Riganti C; Castella B; Massaia M
    Front Immunol; 2018; 9():1246. PubMed ID: 29937767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Butyrophilin 3A1 binds phosphorylated antigens and stimulates human γδ T cells.
    Vavassori S; Kumar A; Wan GS; Ramanjaneyulu GS; Cavallari M; El Daker S; Beddoe T; Theodossis A; Williams NK; Gostick E; Price DA; Soudamini DU; Voon KK; Olivo M; Rossjohn J; Mori L; De Libero G
    Nat Immunol; 2013 Sep; 14(9):908-16. PubMed ID: 23872678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphinophosphonates and Their Tris-pivaloyloxymethyl Prodrugs Reveal a Negatively Cooperative Butyrophilin Activation Mechanism.
    Shippy RR; Lin X; Agabiti SS; Li J; Zangari BM; Foust BJ; Poe MM; Hsiao CC; Vinogradova O; Wiemer DF; Wiemer AJ
    J Med Chem; 2017 Mar; 60(6):2373-2382. PubMed ID: 28218845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
    Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
    Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.